iPSC Gene Editing
- Services
- Workflow
- Applications
- Features
- FAQ
- Explore Other Options
Human induced pluripotent stem cells (iPSCs) provide a powerful platform for disease modeling, drug discovery, functional genomics, and cell therapy research. Our iPSC Gene Editing Services combine advanced genome engineering technologies with extensive stem cell expertise to generate customized iPSC models—including gene knockouts, knock-ins, point mutations, reporter integrations, and other targeted genetic modifications. From project design and clone screening to comprehensive validation and delivery, we provide end-to-end solutions tailored to your research objectives.
What We Can Edit in iPSCs
Gene Knockout
Generate loss-of-function iPSC models through targeted disruption of coding regions, enabling functional studies and disease mechanism investigations.
Gene Knock-in
Insert therapeutic genes, fluorescent reporters, disease-associated variants, or expression cassettes into predefined genomic loci.
Point Mutation Engineering
Introduce or correct clinically relevant mutations to establish genetically defined disease models and matched control cell lines.
Reporter Cell Line Development
Create stable reporter iPSC lines expressing fluorescent or luminescent markers for differentiation tracking, pathway monitoring, and high-content screening.
Our iPSC Gene Editing Workflow
We follow a rigorous workflow to ensure editing accuracy, genomic integrity, and reliable project outcomes.
Sample Requirements and Deliverables
Sample Requirements
Option A: Customer-Supplied iPSCs
- Healthy and actively growing cultures
- Confirmed pluripotent status
- Mycoplasma-free
- Viability ≥ 80%
Option B: Utilize Our Existing iPSC Resources
We can initiate projects using our well-characterized healthy donor or disease-relevant iPSC lines when applicable.
Deliverables
- Edited iPSC clones
- Genotyping report
- Target locus verification
- Cryopreserved cell stocks
- Comprehensive quality control (QC) Analysis
Applications
Engineered iPSC models support a wide range of research and translational applications.
Disease Modeling
Develop genetically defined cellular models of neurological, cardiovascular, metabolic, oncological, and rare genetic diseases to investigate disease mechanisms and identify therapeutic targets.
Drug Discovery & Functional Genomics
Support target validation, pathway analysis, phenotypic screening, mechanism-of-action studies, and efficacy assessment using genetically engineered human cellular models.
Regenerative Medicine
Design tailored iPSC lines for next-generation cellular therapies, immunoengineering approaches, regenerative medicine research and translational development projects.
Reporter Cell Lines & Assay Development
Establish customized reporter iPSC models for differentiation tracking, pathway monitoring, high-content imaging, and drug screening applications.
Why Choose Creative Bioarray's iPSC Gene Editing Service
Extensive iPSC Expertise
Deep experience in iPSC culture, expansion, characterization, and genome engineering.
Customized Editing Strategies
Solutions tailored to your project goals and target gene characteristics.
Comprehensive Clone Validation
Multi-level validation including genotyping, sequencing, pluripotency assessment, and genomic stability analysis.
High-Quality iPSC Models
Generation of genetically defined disease models, reporter lines, and isogenic control cell lines.
End-to-End Project Support
Complete support from experimental design through clone delivery.
Reliable Turnaround and Communication
Dedicated project management and transparent communication throughout the project lifecycle.
FAQ
What types of genetic modifications can be performed in iPSCs?
We support gene knockout, gene knock-in, point mutation introduction, mutation correction, reporter integration, safe harbor engineering, and other customized genome engineering projects.
How can you prove that genome editing worked?
Validation may include genotyping, sequencing analysis, integration verification and other quality control assessments depending on the project needs.
Will genome editing affect pluripotency?
Our workflows are designed to maintain the pluripotent characteristics of edited iPSC clones. Pluripotency assessment can be included as part of project validation.
Can edited iPSCs be differentiated into downstream cell types?
Yes. Edited iPSCs can subsequently be differentiated into neurons, cardiomyocytes, hepatocytes, immune cells, and other specialized cell types for downstream studies.
Do you provide custom project design?
Absolutely. Each project is customized according to the target gene, desired modification, cell line background, and research objectives.
Accelerate Your iPSC Research with Precision Genome Engineering
Whether you need disease-specific iPSC models, genetically matched control lines, reporter cell lines, or customized genome engineering solutions, our experienced team can help you move your project from concept to validated cell models.
Contact us today to discuss your iPSC gene editing project and receive a customized technical proposal.
Explore Other Options
